154 related articles for article (PubMed ID: 27031698)
1. Critical Endothelial Regulation by LRP5 during Retinal Vascular Development.
Huang W; Li Q; Amiry-Moghaddam M; Hokama M; Sardi SH; Nagao M; Warman ML; Olsen BR
PLoS One; 2016; 11(3):e0152833. PubMed ID: 27031698
[TBL] [Abstract][Full Text] [Related]
2. Deletion of LRP5 in VLDLR knockout mice inhibits retinal neovascularization.
Xia CH; Lu E; Zeng J; Gong X
PLoS One; 2013; 8(9):e75186. PubMed ID: 24058663
[TBL] [Abstract][Full Text] [Related]
3. LRP5 is required for vascular development in deeper layers of the retina.
Xia CH; Yablonka-Reuveni Z; Gong X
PLoS One; 2010 Jul; 5(7):e11676. PubMed ID: 20652025
[TBL] [Abstract][Full Text] [Related]
4. Retinal expression of Wnt-pathway mediated genes in low-density lipoprotein receptor-related protein 5 (Lrp5) knockout mice.
Chen J; Stahl A; Krah NM; Seaward MR; Joyal JS; Juan AM; Hatton CJ; Aderman CM; Dennison RJ; Willett KL; Sapieha P; Smith LE
PLoS One; 2012; 7(1):e30203. PubMed ID: 22272305
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic Activation of Wnt Signaling by Lithium Normalizes Retinal Vasculature in a Murine Model of Familial Exudative Vitreoretinopathy.
Wang Z; Liu CH; Sun Y; Gong Y; Favazza TL; Morss PC; Saba NJ; Fredrick TW; He X; Akula JD; Chen J
Am J Pathol; 2016 Oct; 186(10):2588-600. PubMed ID: 27524797
[TBL] [Abstract][Full Text] [Related]
6. Low-Density Lipoprotein Receptor-Related Protein 5-Deficient Rats Have Reduced Bone Mass and Abnormal Development of the Retinal Vasculature.
Ubels JL; Diegel CR; Foxa GE; Ethen NJ; Lensing JN; Madaj ZB; Williams BO
CRISPR J; 2020 Aug; 3(4):284-298. PubMed ID: 32833527
[TBL] [Abstract][Full Text] [Related]
7. Structure and function of the retina of low-density lipoprotein receptor-related protein 5 (Lrp5)-deficient rats.
Ubels JL; Lin CM; Antonetti DA; Diaz-Coranguez M; Diegel CR; Williams BO
Exp Eye Res; 2022 Apr; 217():108977. PubMed ID: 35139333
[TBL] [Abstract][Full Text] [Related]
8. A mutagenesis-derived
Charette JR; Earp SE; Bell BA; Ackert-Bicknell CL; Godfrey DA; Rao S; Anand-Apte B; Nishina PM; Peachey NS
Mol Vis; 2017; 23():140-148. PubMed ID: 28356706
[TBL] [Abstract][Full Text] [Related]
9. A model for familial exudative vitreoretinopathy caused by LPR5 mutations.
Xia CH; Liu H; Cheung D; Wang M; Cheng C; Du X; Chang B; Beutler B; Gong X
Hum Mol Genet; 2008 Jun; 17(11):1605-12. PubMed ID: 18263894
[TBL] [Abstract][Full Text] [Related]
10. Lrp5 and Lrp6 play compensatory roles in mouse intestinal development.
Zhong Z; Baker JJ; Zylstra-Diegel CR; Williams BO
J Cell Biochem; 2012 Jan; 113(1):31-8. PubMed ID: 21866564
[TBL] [Abstract][Full Text] [Related]
11. Norrin stimulates cell proliferation in the superficial retinal vascular plexus and is pivotal for the recruitment of mural cells.
Zuercher J; Fritzsche M; Feil S; Mohn L; Berger W
Hum Mol Genet; 2012 Jun; 21(12):2619-30. PubMed ID: 22394677
[TBL] [Abstract][Full Text] [Related]
12. Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization.
Ye X; Wang Y; Cahill H; Yu M; Badea TC; Smallwood PM; Peachey NS; Nathans J
Cell; 2009 Oct; 139(2):285-98. PubMed ID: 19837032
[TBL] [Abstract][Full Text] [Related]
13. Wnt signaling mediates pathological vascular growth in proliferative retinopathy.
Chen J; Stahl A; Krah NM; Seaward MR; Dennison RJ; Sapieha P; Hua J; Hatton CJ; Juan AM; Aderman CM; Willett KL; Guerin KI; Mammoto A; Campbell M; Smith LE
Circulation; 2011 Oct; 124(17):1871-81. PubMed ID: 21969016
[TBL] [Abstract][Full Text] [Related]
14. Canonical WNT signaling components in vascular development and barrier formation.
Zhou Y; Wang Y; Tischfield M; Williams J; Smallwood PM; Rattner A; Taketo MM; Nathans J
J Clin Invest; 2014 Sep; 124(9):3825-46. PubMed ID: 25083995
[TBL] [Abstract][Full Text] [Related]
15. β-Catenin-dependent pathway activation by both promiscuous "canonical" WNT3a-, and specific "noncanonical" WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency.
Ring L; Neth P; Weber C; Steffens S; Faussner A
Cell Signal; 2014 Feb; 26(2):260-7. PubMed ID: 24269653
[TBL] [Abstract][Full Text] [Related]
16. LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders.
Levasseur R; Lacombe D; de Vernejoul MC
Joint Bone Spine; 2005 May; 72(3):207-14. PubMed ID: 15850991
[TBL] [Abstract][Full Text] [Related]
17. Opposing Roles of Wnt Inhibitors IGFBP-4 and Dkk1 in Cardiac Ischemia by Differential Targeting of LRP5/6 and β-catenin.
Wo D; Peng J; Ren DN; Qiu L; Chen J; Zhu Y; Yan Y; Yan H; Wu J; Ma E; Zhong TP; Chen Y; Liu Z; Liu S; Ao L; Liu Z; Jiang C; Peng J; Zou Y; Qian Q; Zhu W
Circulation; 2016 Dec; 134(24):1991-2007. PubMed ID: 27803037
[TBL] [Abstract][Full Text] [Related]
18. Dietary Compound Chrysin Inhibits Retinal Neovascularization with Abnormal Capillaries in db/db Mice.
Kang MK; Park SH; Kim YH; Lee EJ; Antika LD; Kim DY; Choi YJ; Kang YH
Nutrients; 2016 Dec; 8(12):. PubMed ID: 27918469
[TBL] [Abstract][Full Text] [Related]
19. Reversing LRP5-dependent osteoporosis and SOST deficiency-induced sclerosing bone disorders by altering WNT signaling activity.
Chang MK; Kramer I; Keller H; Gooi JH; Collett C; Jenkins D; Ettenberg SA; Cong F; Halleux C; Kneissel M
J Bone Miner Res; 2014 Jan; 29(1):29-42. PubMed ID: 23901037
[TBL] [Abstract][Full Text] [Related]
20. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells.
Peröbner I; Karow M; Jochum M; Neth P
Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
